{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T05:14:51Z","timestamp":1794719691649,"version":"4.9.1"},"publisher-location":"Cham","reference-count":79,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031065651","type":"print"},{"value":"9783031065668","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-031-06566-8_9","type":"book-chapter","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T14:02:43Z","timestamp":1665842563000},"page":"217-234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PI3K Isoforms in CD8+ T Cell Development and Function"],"prefix":"10.1007","author":[{"given":"Pankaj","family":"Gaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikayel","family":"Mkrtichyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazli","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Hattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir N.","family":"Khleif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,16]]},"reference":[{"issue":"15","key":"9_CR1","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1158\/0008-5472.CAN-16-1925","volume":"77","author":"R Abu Eid","year":"2017","unstructured":"Abu Eid R, Ahmad S, Lin Y, Webb M, Berrong Z, Shrimali R, Kumai T, Ananth S, Rodriguez PC, Celis E, Janik J, Mkrtichyan M, Khleif SN (2017) Enhanced therapeutic efficacy and memory of tumor-specific CD8 T cells by Ex Vivo PI3K-\u03b4 inhibition. Cancer Res 77(15):4135\u20134145","journal-title":"Cancer Res"},{"issue":"5","key":"9_CR2","doi-asserted-by":"publisher","first-page":"e1005448","DOI":"10.1080\/2162402X.2015.1005448","volume":"4","author":"R Abu Eid","year":"2015","unstructured":"Abu Eid R, Friedman KM, Mkrtichyan M, Walens A, King W, Janik J, Khleif SN (2015) Akt1 and-2 inhibition diminishes terminal differentiation and enhances central memory CD8+ T-cell proliferation and survival. Oncoimmunology 4(5):e1005448","journal-title":"Oncoimmunology"},{"key":"9_CR3","doi-asserted-by":"crossref","unstructured":"Aragoneses-Fenoll L, Ojeda G, Montes-Casado M, Acosta-Ampudia Y, Dianzani U, Portol\u00e9s P, Rojo JM (2018) T-cell-specific loss of the PI-3-Kinase p110\u03b1 catalytic subunit results in enhanced cytokine production and antitumor response. Front Immunol 9(332)","DOI":"10.3389\/fimmu.2018.00332"},{"issue":"7251","key":"9_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08155","volume":"460","author":"K Araki","year":"2009","unstructured":"Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, Larsen CP, Ahmed R (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460(7251):108\u2013112","journal-title":"Nature"},{"issue":"3","key":"9_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2217\/imt.10.107","volume":"3","author":"EV Barsov","year":"2011","unstructured":"Barsov EV (2011) Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy. Immunotherapy 3(3):407\u2013421","journal-title":"Immunotherapy"},{"key":"9_CR6","doi-asserted-by":"crossref","unstructured":"Basu A, Lambring CB (2021) Akt Isoforms: a family affair in breast cancer. Cancers (Basel) 13(14)","DOI":"10.3390\/cancers13143445"},{"issue":"8","key":"9_CR8","doi-asserted-by":"publisher","first-page":"a002436","DOI":"10.1101\/cshperspect.a002436","volume":"2","author":"JS Boomer","year":"2010","unstructured":"Boomer JS, Green JM (2010) An enigmatic tail of CD28 signaling. Cold Spring Harb Perspect Biol 2(8):a002436","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9_CR9","doi-asserted-by":"crossref","unstructured":"Borsa M, Barnstorf I, Baumann NS, Pallmer K, Yermanos A, Gr\u00e4bnitz F, Barandun N, Hausmann A, Sandu I, Barral Y, Oxenius A (2019) Modulation of asymmetric cell division as a mechanism to boost CD8(+) T cell memory. Sci Immunol 4(34)","DOI":"10.1126\/sciimmunol.aav1730"},{"issue":"7","key":"9_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1634\/theoncologist.2016-0145","volume":"21","author":"MI Carlo","year":"2016","unstructured":"Carlo MI, Molina AM, Lakhman Y, Patil S, Woo K, DeLuca J, Lee C-H, Hsieh JJ, Feldman DR, Motzer RJ, Voss MH (2016) A phase Ib study of BEZ235, a dual inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in patients with advanced renal cell carcinoma. Oncologist 21(7):787\u2013788","journal-title":"Oncologist"},{"issue":"1","key":"9_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s40425-018-0457-0","volume":"6","author":"LS Carnevalli","year":"2018","unstructured":"Carnevalli LS, Sinclair C, Taylor MA, Gutierrez PM, Langdon S, Coenen-Stass AML, Mooney L, Hughes A, Jarvis L, Staniszewska A, Crafter C, Sidders B, Hardaker E, Hudson K, Barry ST (2018) PI3K\u03b1\/\u03b4 inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity. J Immunother Cancer 6(1):158","journal-title":"J Immunother Cancer"},{"issue":"41","key":"9_CR12","doi-asserted-by":"publisher","first-page":"36076","DOI":"10.1074\/jbc.M111.259549","volume":"286","author":"J Cheng","year":"2011","unstructured":"Cheng J, Phong B, Wilson DC, Hirsch R, Kane LP (2011) Akt fine-tunes NF-\u03baB-dependent gene expression during T cell activation. J Biol Chem 286(41):36076\u201336085","journal-title":"J Biol Chem"},{"issue":"4","key":"9_CR13","doi-asserted-by":"publisher","first-page":"C929","DOI":"10.1152\/ajpcell.00461.2009","volume":"298","author":"NM Dagia","year":"2010","unstructured":"Dagia NM, Agarwal G, Kamath DV, Chetrapal-Kunwar A, Gupte RD, Jadhav MG, Dadarkar SS, Trivedi J, Kulkarni-Almeida AA, Kharas F (2010) A preferential p110\u03b1\/\u03b3 PI3K inhibitor attenuates experimental inflammation by suppressing the production of proinflammatory mediators in a NF-\u03baB-dependent manner. Am J Physiol Cell Physiol 298(4):C929\u2013C941","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7629","key":"9_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","volume":"539","author":"O De Henau","year":"2016","unstructured":"De Henau O, Rausch M, Winkler D, Campesato LF, Liu C, Cymerman DH, Budhu S, Ghosh A, Pink M, Tchaicha J, Douglas M, Tibbitts T, Sharma S, Proctor J, Kosmider N, White K, Stern H, Soglia J, Adams J, Palombella VJ, McGovern K, Kutok JL, Wolchok JD, Merghoub T (2016) Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells. Nature 539(7629):443\u2013447","journal-title":"Nature"},{"issue":"4","key":"9_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, Xiao B, Worley PF, Powell JD (2011) The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 12(4):295\u2013303","journal-title":"Nat Immunol"},{"issue":"42","key":"9_CR16","doi-asserted-by":"publisher","first-page":"E8865","DOI":"10.1073\/pnas.1618916114","volume":"114","author":"A Delpoux","year":"2017","unstructured":"Delpoux A, Lai C-Y, Hedrick SM, Doedens AL (2017) FOXO1 opposition of CD8+ T cell effector programming confers early memory properties and phenotypic diversity. Proc Natl Acad Sci 114(42):E8865\u2013E8874","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"9_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.annonc.2020.10.596","volume":"32","author":"S Dent","year":"2021","unstructured":"Dent S, Cort\u00e9s J, Im YH, Di\u00e9ras V, Harbeck N, Krop IE, Wilson TR, Cui N, Schimmoller F, Hsu JY, He J, De Laurentiis M, Sousa S, Drullinsky P, Jacot W (2021) Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial. Ann Oncol 32(2):197\u2013207","journal-title":"Ann Oncol"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3389\/fonc.2020.01221","volume":"10","author":"A Dimou","year":"2020","unstructured":"Dimou A, Syrigos KN (2020) The role of GSK3\u03b2 in T lymphocytes in the tumor microenvironment. Front Oncol 10:1221","journal-title":"Front Oncol"},{"key":"9_CR19","doi-asserted-by":"crossref","unstructured":"Dituri F, Mazzocca A, Giannelli G, Antonaci S (2011) PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors. Clin Dev Immunol","DOI":"10.1155\/2011\/947858"},{"issue":"24","key":"9_CR20","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1182\/blood-2014-07-587279","volume":"124","author":"S Dong","year":"2014","unstructured":"Dong S, Guinn D, Dubovsky JA, Zhong Y, Lehman A, Kutok J, Woyach JA, Byrd JC, Johnson AJ (2014) IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells. Blood 124(24):3583\u20133586","journal-title":"Blood"},{"issue":"9","key":"9_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/eji.201948455","volume":"50","author":"CJ Dwyer","year":"2020","unstructured":"Dwyer CJ, Arhontoulis DC, Rangel Rivera GO, Knochelmann HM, Smith AS, Wyatt MM, Rubinstein MP, Atkinson C, Thaxton JE, Neskey DM, Paulos CM (2020) Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells. Eur J Immunol 50(9):1386\u20131399","journal-title":"Eur J Immunol"},{"key":"9_CR22","doi-asserted-by":"crossref","unstructured":"Finlay D (2012) Regulation of glucose metabolism in T cells: new insight into the role of Phosphoinositide 3-kinases. Front Immunol 3(247)","DOI":"10.3389\/fimmu.2012.00247"},{"issue":"4","key":"9_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT (2017) The PI3K pathway in human disease. Cell 170(4):605\u2013635","journal-title":"Cell"},{"issue":"12","key":"9_CR24","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.4049\/jimmunol.180.12.7958","volume":"180","author":"J Gagnon","year":"2008","unstructured":"Gagnon J, Ramanathan S, Leblanc C, Cloutier A, McDonald PP, Ilangumaran S (2008) IL-6, in synergy with IL-7 or IL-15, stimulates TCR-independent proliferation and functional differentiation of CD8+ T Lymphocytes. J Immunol 180(12):7958\u20137968","journal-title":"J Immunol"},{"issue":"3","key":"9_CR25","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1182\/blood-2007-08-108050","volume":"111","author":"F Gar\u00e7on","year":"2008","unstructured":"Gar\u00e7on F, Patton DT, Emery JL, Hirsch E, Rottapel R, Sasaki T, Okkenhaug K (2008) CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85\/p110 heterodimer. Blood 111(3):1464\u20131471","journal-title":"Blood"},{"issue":"7","key":"9_CR26","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nm.1982","volume":"15","author":"L Gattinoni","year":"2009","unstructured":"Gattinoni L, Zhong X-S, Palmer DC, Ji Y, Hinrichs CS, Yu Z, Wrzesinski C, Boni A, Cassard L, Garvin LM, Paulos CM, Muranski P, Restifo NP (2009) Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med 15(7):808\u2013813","journal-title":"Nat Med"},{"issue":"3","key":"9_CR27","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4049\/jimmunol.1501890","volume":"196","author":"DT Gracias","year":"2016","unstructured":"Gracias DT, Boesteanu AC, Fraietta JA, Hope JL, Carey AJ, Mueller YM, Kawalekar OU, Fike AJ, June CH, Katsikis PD (2016) Phosphatidylinositol 3-Kinase p110\u03b4 isoform regulates CD8+ T Cell responses during acute viral and intracellular bacterial infections. J Immunol 196(3):1186\u20131198","journal-title":"J Immunol"},{"issue":"38","key":"9_CR28","doi-asserted-by":"publisher","first-page":"16601","DOI":"10.1073\/pnas.1003457107","volume":"107","author":"TW Hand","year":"2010","unstructured":"Hand TW, Cui W, Jung YW, Sefik E, Joshi NS, Chandele A, Liu Y, Kaech SM (2010) Differential effects of STAT5 and PI3K\/AKT signaling on effector and memory CD8 T-cell survival. Proc Natl Acad Sci 107(38):16601\u201316606","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"9_CR29","doi-asserted-by":"publisher","first-page":"150208","DOI":"10.1098\/rsob.150208","volume":"6","author":"M Haque","year":"2016","unstructured":"Haque M, Song J, Fino K, Wang Y, Sandhu P, Song X, Norbury C, Ni B, Fang D, Salek-Ardakani S, Song J (2016) C-Myc regulation by costimulatory signals modulates the generation of CD8+ memory T cells during viral infection. Open Biol 6(1):150208","journal-title":"Open Biol"},{"key":"9_CR30","doi-asserted-by":"crossref","unstructured":"Hawkins PT, Stephens LR (2015) PI3K signalling in inflammation. Biochimica et Biophysica Acta (BBA)\u2014Mol Cell Biol Lipids 1851(6): 882\u2013897","DOI":"10.1016\/j.bbalip.2014.12.006"},{"issue":"9","key":"9_CR31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nri3278","volume":"12","author":"SM Hedrick","year":"2012","unstructured":"Hedrick SM, Hess Michelini R, Doedens AL, Goldrath AW, Stone EL (2012) FOXO transcription factors throughout T cell biology. Nat Rev Immunol 12(9):649\u2013661","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"9_CR32","doi-asserted-by":"publisher","first-page":"e125832","DOI":"10.1172\/jci.insight.125832","volume":"5","author":"S Hemmati","year":"2019","unstructured":"Hemmati S, Sinclair T, Tong M, Bartholdy B, Okabe RO, Ames K, Ostrodka L, Haque T, Kaur I, Mills TS, Agarwal A, Pietras EM, Zhao JJ, Roberts TM, Gritsman K (2019) PI3 kinase alpha and delta promote hematopoietic stem cell activation. JCI Insight 5(13):e125832","journal-title":"JCI Insight"},{"issue":"10","key":"9_CR33","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","volume":"23","author":"I Hers","year":"2011","unstructured":"Hers I, Vincent EE, Tavar\u00e9 JM (2011) Akt signalling in health and disease. Cell Signal 23(10):1515\u20131527","journal-title":"Cell Signal"},{"issue":"8","key":"9_CR34","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1182\/blood-2017-08-802470","volume":"131","author":"SM Horwitz","year":"2018","unstructured":"Horwitz SM, Koch R, Porcu P, Oki Y, Moskowitz A, Perez M, Myskowski P, Officer A, Jaffe JD, Morrow SN, Allen K, Douglas M, Stern H, Sweeney J, Kelly P, Kelly V, Aster JC, Weaver D, Foss FM, Weinstock DM (2018) Activity of the PI3K-\u03b4, \u03b3 inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma. Blood 131(8):888\u2013898","journal-title":"Blood"},{"issue":"3","key":"9_CR35","first-page":"1154","volume":"118","author":"SJ Jarmin","year":"2008","unstructured":"Jarmin SJ, David R, Ma L, Chai J-G, Dewchand H, Takesono A, Ridley AJ, Okkenhaug K, Marelli-Berg FM (2008) T cell receptor\u2013induced phosphoinositide-3-kinase p110\u03b4 activity is required for T cell localization to antigenic tissue in mice. J Clin Investig 118(3):1154\u20131164","journal-title":"J Clin Investig"},{"issue":"9","key":"9_CR36","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1172\/JCI86437","volume":"126","author":"Y Kagoya","year":"2016","unstructured":"Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, Saso K, Butler MO, Arrowsmith CH, Hirano N (2016) BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Investig 126(9):3479\u20133494","journal-title":"J Clin Investig"},{"issue":"2","key":"9_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ni.1689","volume":"10","author":"YM Kerdiles","year":"2009","unstructured":"Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, DePinho RA, Hedrick SM (2009) Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 10(2):176\u2013184","journal-title":"Nat Immunol"},{"issue":"9","key":"9_CR38","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.4049\/jimmunol.1103568","volume":"188","author":"EH Kim","year":"2012","unstructured":"Kim EH, Sullivan JA, Plisch EH, Tejera MM, Jatzek A, Choi KY, Suresh M (2012) Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J Immunol 188(9):4305\u20134314","journal-title":"J Immunol"},{"key":"9_CR39","doi-asserted-by":"crossref","unstructured":"Kim EH, Suresh M (2013) Role of PI3K\/Akt signaling in memory CD8 T cell differentiation. Front Immunol 4(20)","DOI":"10.3389\/fimmu.2013.00020"},{"issue":"9","key":"9_CR40","doi-asserted-by":"publisher","first-page":"E1659","DOI":"10.1073\/pnas.1608448114","volume":"114","author":"KM Knudson","year":"2017","unstructured":"Knudson KM, Pritzl CJ, Saxena V, Altman A, Daniels MA, Teixeiro E (2017) NF\u03baB\u2013Pim-1\u2013Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci 114(9):E1659\u2013E1667","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"9_CR41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/ni0403-313","volume":"4","author":"S Koyasu","year":"2003","unstructured":"Koyasu S (2003) The role of PI3K in immune cells. Nat Immunol 4(4):313\u2013319","journal-title":"Nat Immunol"},{"issue":"12","key":"9_CR42","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1002\/eji.201343812","volume":"43","author":"N Ladygina","year":"2013","unstructured":"Ladygina N, Gottipati S, Ngo K, Castro G, Ma JY, Banie H, Rao TS, Fung-Leung WP (2013) PI3K\u03b3 kinase activity is required for optimal T-cell activation and differentiation. Eur J Immunol 43(12):3183\u20133196","journal-title":"Eur J Immunol"},{"issue":"2","key":"9_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274\u2013293","journal-title":"Cell"},{"issue":"7","key":"9_CR44","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.4049\/jimmunol.1103365","volume":"188","author":"Q Li","year":"2012","unstructured":"Li Q, Rao R, Vazzana J, Goedegebuure P, Odunsi K, Gillanders W, Shrikant PA (2012) Regulating mammalian target of rapamycin to tune vaccination-induced CD8+ T cell responses for tumor immunity. J Immunol 188(7):3080\u20133087","journal-title":"J Immunol"},{"issue":"7","key":"9_CR45","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.4049\/jimmunol.174.7.4019","volume":"174","author":"Y Li","year":"2005","unstructured":"Li Y, Zhi W, Wareski P, Weng N-P (2005) IL-15 activates telomerase and minimizes telomere loss and may preserve the replicative life span of memory CD8+ T cells in vitro. J Immunol 174(7):4019\u20134024","journal-title":"J Immunol"},{"issue":"3","key":"9_CR46","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.4049\/jimmunol.0901099","volume":"183","author":"D Liu","year":"2009","unstructured":"Liu D, Zhang T, Marshall AJ, Okkenhaug K, Vanhaesebroeck B, Uzonna JE (2009) The p110\u03b4 isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J Immunol 183(3):1921\u20131933","journal-title":"J Immunol"},{"issue":"11","key":"9_CR47","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri.2016.93","volume":"16","author":"CL Lucas","year":"2016","unstructured":"Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K (2016) PI3K\u03b4 and primary immunodeficiencies. Nat Rev Immunol 16(11):702\u2013714","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"9_CR48","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.immuni.2011.01.012","volume":"34","author":"AN Macintyre","year":"2011","unstructured":"Macintyre AN, Finlay D, Preston G, Sinclair LV, Waugh CM, Tamas P, Feijoo C, Okkenhaug K, Cantrell DA (2011) Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 34(2):224\u2013236","journal-title":"Immunity"},{"issue":"7","key":"9_CR49","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC (2007) AKT\/PKB signaling: navigating downstream. Cell 129(7):1261\u20131274","journal-title":"Cell"},{"issue":"3","key":"9_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A (2017) AKT\/PKB signaling: navigating the network. Cell 169(3):381\u2013405","journal-title":"Cell"},{"issue":"4","key":"9_CR51","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.4049\/jimmunol.180.4.2081","volume":"180","author":"AL Martin","year":"2008","unstructured":"Martin AL, Schwartz MD, Jameson SC, Shimizu Y (2008) Selective regulation of CD8 effector T cell migration by the p110\u03b3 isoform of phosphatidylinositol 3-kinase. J Immunol 180(4):2081\u20132088","journal-title":"J Immunol"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"105900","DOI":"10.1016\/j.phrs.2021.105900","volume":"173","author":"D Meng","year":"2021","unstructured":"Meng D, He W, Zhang Y, Liang Z, Zheng J, Zhang X, Zheng X, Zhan P, Chen H, Li W, Cai L (2021) Development of PI3K inhibitors: advances in clinical trials and new strategies (review). Pharmacol Res 173:105900","journal-title":"Pharmacol Res"},{"issue":"6","key":"9_CR53","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1084\/jem.20130392","volume":"210","author":"RH Michelini","year":"2013","unstructured":"Michelini RH, Doedens AL, Goldrath AW, Hedrick SM (2013) Differentiation of CD8 memory T cells depends on Foxo1. J Exp Med 210(6):1189\u20131200","journal-title":"J Exp Med"},{"key":"9_CR54","doi-asserted-by":"crossref","unstructured":"Munoz J, Follows GA, Nastoupil LJ (2021) Copanlisib for the treatment of malignant lymphoma: clinical experience and future perspectives. Targeted Oncol","DOI":"10.1007\/s11523-021-00802-9"},{"key":"9_CR55","doi-asserted-by":"crossref","unstructured":"Murter B, Kane LP (2020) Control of T lymphocyte fate decisions by PI3K signaling. F1000Res 9","DOI":"10.12688\/f1000research.26928.1"},{"issue":"10","key":"9_CR56","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.2217\/imt.11.100","volume":"3","author":"JC Nolz","year":"2011","unstructured":"Nolz JC, Starbeck-Miller GR, Harty JT (2011) Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions. Immunotherapy 3(10):1223\u20131233","journal-title":"Immunotherapy"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1146\/annurev-immunol-032712-095946","volume":"31","author":"K Okkenhaug","year":"2013","unstructured":"Okkenhaug K (2013) Signaling by the phosphoinositide 3-kinase family in immune cells. Annu Rev Immunol 31:675\u2013704","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"9_CR58","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1158\/2159-8290.CD-16-0716","volume":"6","author":"K Okkenhaug","year":"2016","unstructured":"Okkenhaug K, Graupera M, Vanhaesebroeck B (2016) Targeting PI3K in cancer: impact on tumor cells, their protective stroma, angiogenesis, and immunotherapy. Cancer Discov 6(10):1090\u20131105","journal-title":"Cancer Discov"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fimmu.2014.00557","volume":"5","author":"K Okkenhaug","year":"2014","unstructured":"Okkenhaug K, Turner M, Gold MR (2014) PI3K signaling in B cell and T cell biology. Front Immunol 5:557","journal-title":"Front Immunol"},{"issue":"4","key":"9_CR60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nri1056","volume":"3","author":"K Okkenhaug","year":"2003","unstructured":"Okkenhaug K, Vanhaesebroeck B (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 3(4):317\u2013330","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"9_CR61","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.4049\/jimmunol.1501227","volume":"195","author":"VQ Pearce","year":"2015","unstructured":"Pearce VQ, Bouabe H, MacQueen AR, Carbonaro V, Okkenhaug K (2015) PI3K\u03b4 regulates the magnitude of CD8+ T cell responses after challenge with listeria monocytogenes. J Immunol 195(7):3206\u20133217","journal-title":"J Immunol"},{"issue":"3","key":"9_CR62","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2012.01.015","volume":"36","author":"RR Rao","year":"2012","unstructured":"Rao RR, Li Q, Bupp MRG, Shrikant PA (2012) Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8+ T cell differentiation. Immunity 36(3):374\u2013387","journal-title":"Immunity"},{"issue":"1","key":"9_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.immuni.2009.10.010","volume":"32","author":"RR Rao","year":"2010","unstructured":"Rao RR, Li Q, Odunsi K, Shrikant PA (2010) The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32(1):67\u201378","journal-title":"Immunity"},{"issue":"4","key":"9_CR64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12(4):269\u2013281","journal-title":"Nat Rev Immunol"},{"issue":"6754","key":"9_CR65","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, F\u00f6rster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754):708\u2013712","journal-title":"Nature"},{"issue":"4","key":"9_CR66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri1052","volume":"3","author":"KS Schluns","year":"2003","unstructured":"Schluns KS, Lefran\u00e7ois L (2003) Cytokine control of memory T-cell development and survival. Nat Rev Immunol 3(4):269\u2013279","journal-title":"Nat Rev Immunol"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ebiom.2016.01.019","volume":"4","author":"G Scholz","year":"2016","unstructured":"Scholz G, Jandus C, Zhang L, Grandclement C, Lopez-Mejia IC, Soneson C, Delorenzi M, Fajas L, Held W, Dormond O, Romero P (2016) Modulation of mTOR signalling triggers the formation of stem cell-like memory T cells. EBioMedicine 4:50\u201361","journal-title":"EBioMedicine"},{"issue":"1","key":"9_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1124\/jpet.120.265538","volume":"374","author":"N Shin","year":"2020","unstructured":"Shin N, Stubbs M, Koblish H, Yue EW, Soloviev M, Douty B, Wang KH, Wang Q, Gao M, Feldman P, Yang G, Hall L, Hansbury M, O\u2019Connor S, Leffet L, Collins R, Katiyar K, He X, Waeltz P, Collier P, Lu J, Li Y-L, Li Y, Liu PCC, Burn T, Covington M, Diamond S, Shuey D, Roberts A, Yeleswaram S, Hollis G, Metcalf B, Yao W, Huber R, Combs A, Newton R, Scherle P (2020) Parsaclisib is a next-generation Phosphoinositide 3-Kinase \u03b4 inhibitor with reduced hepatotoxicity and potent antitumor and immunomodulatory activities in models of B-cell malignancy. J Pharmacol Exp Ther 374(1):211\u2013222","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"9_CR69","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ni.1603","volume":"9","author":"LV Sinclair","year":"2008","unstructured":"Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, Ager A, Okkenhaug K, Hagenbeek TJ, Spits H, Cantrell DA (2008) Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 9(5):513\u2013521","journal-title":"Nat Immunol"},{"key":"9_CR71","doi-asserted-by":"crossref","unstructured":"Sowell RT, Marzo AL (2015) Resident-memory CD8 T cells and mTOR: generation, protection, and clinical importance. Front Immunol 6(38)","DOI":"10.3389\/fimmu.2015.00038"},{"key":"9_CR72","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2015.05.017","volume":"23","author":"A-K Stark","year":"2015","unstructured":"Stark A-K, Sriskantharajah S, Hessel EM, Okkenhaug K (2015) PI3K inhibitors in inflammation, autoimmunity and cancer. Curr Opin Pharmacol 23:82\u201391","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"9_CR73","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1182\/blood-2005-08-3300","volume":"107","author":"W Swat","year":"2006","unstructured":"Swat W, Montgrain V, Doggett TA, Douangpanya J, Puri K, Vermi W, Diacovo TG (2006) Essential role of PI3K\u03b4 and PI3K\u03b3 in thymocyte survival. Blood 107(6):2415\u20132422","journal-title":"Blood"},{"issue":"5","key":"9_CR74","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/cas.13561","volume":"109","author":"K Tamura","year":"2018","unstructured":"Tamura K, Kodaira M, Shimizu C, Yonemori K, Yunokawa M, Shimomura A, Kobayashi T, Nakano K, Tomomatsu J, Ito Y, Tanaka J, Kuriki H, Gu Z, Takahashi S (2018) Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer. Cancer Sci 109(5):1592\u20131601","journal-title":"Cancer Sci"},{"issue":"1","key":"9_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41590-020-00818-9","volume":"22","author":"V Verma","year":"2021","unstructured":"Verma V, Jafarzadeh N, Boi S, Kundu S, Jiang Z, Fan Y, Lopez J, Nandre R, Zeng P, Alolaqi F, Ahmad S, Gaur P, Barry ST, Valge-Archer VE, Smith PD, Banchereau J, Mkrtichyan M, Youngblood B, Rodriguez PC, Gupta S, Khleif SN (2021) MEK inhibition reprograms CD8(+) T lymphocytes into memory stem cells with potent antitumor effects. Nat Immunol 22(1):53\u201366","journal-title":"Nat Immunol"},{"key":"9_CR77","doi-asserted-by":"crossref","unstructured":"Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM Ugolini S (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331(6013):44\u201349","DOI":"10.1126\/science.1198687"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"594620","DOI":"10.3389\/fimmu.2020.594620","volume":"11","author":"F Watkinson","year":"2021","unstructured":"Watkinson F, Nayar SK, Rani A, Sakellariou CA, Elhage O, Papaevangelou E, Dasgupta P, Galustian C (2021) IL-15 upregulates telomerase expression and potently increases proliferative capacity of NK, NKT-like, and CD8 T cells. Front Immunol 11:594620\u2013594620","journal-title":"Front Immunol"},{"key":"9_CR80","doi-asserted-by":"crossref","unstructured":"Watkinson F, Nayar Sk, Rani A, Sakellariou CA, Elhage O, Papaevangelou E, Dasgupta P, Galustian C (2021) IL-15 upregulates telomerase expression and potently increases proliferative capacity of NK, NKT-like, and CD8 T cells. Front Immunol 11(3514)","DOI":"10.3389\/fimmu.2020.594620"},{"issue":"5","key":"9_CR81","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.4049\/jimmunol.175.5.2783","volume":"175","author":"LMC Webb","year":"2005","unstructured":"Webb LMC, Vigorito E, Wymann MP, Hirsch E, Turner M (2005) Cutting edge: T cell development requires the combined activities of the p110\u03b3 and p110\u03b4 catalytic isoforms of Phosphatidylinositol 3-Kinase. J Immunol 175(5):2783\u20132787","journal-title":"J Immunol"},{"issue":"1","key":"9_CR82","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X (2019) Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer 18(1):26","journal-title":"Mol Cancer"},{"issue":"88","key":"9_CR83","doi-asserted-by":"publisher","first-page":"35807","DOI":"10.18632\/oncotarget.26334","volume":"9","author":"W Zheng","year":"2018","unstructured":"Zheng W, Jones LL, Geiger TL (2018) Modulation of PI3K signaling to improve CAR T cell function. Oncotarget 9(88):35807\u201335808","journal-title":"Oncotarget"}],"container-title":["Current Topics in Microbiology and Immunology","PI3K and AKT Isoforms in Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-06566-8_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T15:39:31Z","timestamp":1665848371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-06566-8_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031065651","9783031065668"],"references-count":79,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-06566-8_9","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-031-06566-8","asserted-by":"object"}]},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"16 October 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}